Study Finds No Drug-Drug Interaction Between Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg Capsules and Omeprazole, a Widely Used PPI – Phramalive.com

RIDGEFIELD, Conn., Feb. 3, 2012 /PRNewswire/ — Boehringer Ingelheim presented results of a drug interaction study that found Aggrenox® (aspirin/extended-release dipyridamole), an antiplatelet medication, is not affected by the co-administration of …